As well-appreciated biomarkers, tumor markers have been spotlighted as reliable tools for
predicting the behavior of different tumors and helping clinicians ascertain the type of …

The advanced, metastatic differentiated thyroid cancers (DTCs) have a poor prognosis
mainly owing to radioactive iodine (RAI) refractoriness caused by decreased expression of …

Background: Indolent nature but a high incidence of differentiated thyroid cancer (DTC)
remains a challenge for optimizing patient care. Therefore, prognostic factors present …

Thyroid cancer is the predominant endocrine-related malignancy. ST6 β-galactoside α2, 6-
sialyltransferase 1 (ST6GAL1) has been studied in various types of cancers; however, the …

Thyroid cancer is among the most prevalent cancers with different types and stages. New
markers are required for the prognosis and diagnosis of the disease. The present study …

Numerous pre-clinical and observational studies have explored the potential effects of
fluoride (F) at varying concentrations on diverse systems and organs. While some have …

Although many efforts have been made to investigate a promising biomarker for the
diagnosis of papillary thyroid cancer (PTC), the currently available biomarkers lack the …

The highly sensitive detection of serum thyroglobulin (Tg) is essential in the post-treatment
follow-up of patients with differentiated thyroid cancer undergoing total or partial …

Background There are no definite recommendations on the optimal time of initiating
radioactive iodine (RAI) therapy for differentiated thyroid cancer (DTC) patients in current …

Tumor biomarkers are substances synthesized by cancer cells or other body cells in
response to cancer and released into the circulation.[1] Tumor biomarkers vary widely in …